NCT02993471View on ClinicalTrials.gov

A Study of Ixekizumab in Participants With Plaque Psoriasis

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 22, 2016

Primary Completion Date

November 21, 2017

Study Completion Date

November 21, 2017

Conditions
Psoriasis
Interventions
DRUG

Drug Cocktail

Administered orally

DRUG

Ixekizumab

Administered SC

Trial Locations (3)

27265

High Point Clinical Trials Center, High Point

32720

Avail Clinical Research LLC, DeLand

92801

Anaheim Clinical Trials, LLC, Anaheim

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02993471 - A Study of Ixekizumab in Participants With Plaque Psoriasis | Biotech Hunter | Biotech Hunter